NCT03918499 2023-03-23IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction CancerCity of Hope Medical CenterPhase 1/2 Completed9 enrolled 9 charts
NCT00210470 2020-12-11A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck CancerBrooklyn ImmunoTherapeutics, LLCPhase 2 Completed27 enrolled 16 charts